Jupiter study

From Aaushi
Jump to navigation Jump to search

Introduction

Study characteristics:

Exclusion criteria (extensive)

Treatment:

Primary endpoint:

Results:

Notes

More general terms

Additional terms

References

  1. Ridker PM et al Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008, 359:2195 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18997196
  2. Hlatky MA Expanding the orbit of primary prevention - Moving beyond Jupiter N Engl J Med 2008, 359:2280 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18997195
  3. Spatz ES et al From here to JUPITER: Identifying new patients for statin therapy using data from the 1999-2004 National Health and Nutrition Examination Survey. Circ Cardiovasc Qual Outcomes 2009 Jan; 2:41. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20031811
    Despres JP. Bringing JUPITER down to earth. Lancet. 2009 Apr 4;373(9670):1147-8. Epub 2009 Mar 28. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19329179
    Kritek P, Campion EW. JUPITER clinical directions--polling results. N Engl J Med. 2009 Mar 5;360(10):e14. No abstract available. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19264683
    Nissen SE. The Jupiter trial: key findings, controversies, and implications. Curr Cardiol Rep. 2009 Mar;11(2):81-2. No abstract available. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19236822
    Fuster V, Bansilal JUPITER strikes earth. Nat Clin Pract Cardiovasc Med. 2009 Mar;6(3):159. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19234496
  4. Glynn RJ et al. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: Exploratory analysis of a randomized trial. Ann Intern Med 2010 Apr 20; 152:488. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20404379
    Zieman SJ and Ouyang P. Statins for primary prevention in older adults: Who is at high risk, who is old, and what denotes primary prevention? Ann Intern Med 2010 Apr 20; 152:528. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20404384
  5. 5.0 5.1 5.2 5.3 de Logeril M et al Cholesterol Lowering, Cardiovascular Diseases, and the Rosuvastatin-JUPITER Controversy Arch Intern Med. 2010;170(12):1032-1036 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/20585068 <Internet> http://archinte.ama-assn.org/cgi/content/short/170/12/1032